Aldicarb sulfoxide | 1646-87-3

• 物质功能分类: 化学试剂 - 有机试剂 - 砜、亚砜类化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Aldicarb sulfoxide
• 英文别名: aldicarbsulfoxide；2-Methyl-2-(methylsulfoxy)-propionaldehyd-O-(methylcarbamoyl)-oxim；[(E)-(2-methyl-2-methylsulfinylpropylidene)amino] N-methylcarbamate
• CAS: 1646-87-3
• 化学式: C₇H₁₄N₂O₃S
• 分子量: 206.266
• InChiKey: BXPMAGSOWXBZHS-WEVVVXLNSA-N

物化性质

• 熔点：
  108-110 °C
• 密度：
  1.2996 (rough estimate)
• 溶解度：
  可溶于水
• 蒸汽压力：
  1.00e-04 mmHg

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  87
• 氢给体数：
  1
• 氢受体数：
  5

ADMET

代谢

氨基甲酸酯通过肝脏酶促水解；降解产物通过肾脏和肝脏排出。

The carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (L793)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 毒性总结

Aldicarb sulfoxide 是一种胆碱酯酶或乙酰胆碱酯酶（AChE）抑制剂。氨基甲酸酯通过与酶的活性位点上的氨基甲酸化形成不稳定的络合物来抑制胆碱酯酶。这种抑制是可逆的。胆碱酯酶抑制剂抑制乙酰胆碱酯酶的作用。由于其基本功能，干扰乙酰胆碱酯酶作用的化学物质是强效的神经毒素，即使在低剂量下也会导致过度流涎和流泪。在高水平暴露下，头痛、流涎、恶心、呕吐、腹痛和腹泻通常是显著的症状。乙酰胆碱酯酶分解在神经和肌肉接头释放的神经递质乙酰胆碱，以允许肌肉或器官放松。乙酰胆碱酯酶抑制的结果是乙酰胆碱积累并继续发挥作用，使得任何神经冲动持续传递，肌肉收缩不会停止。

Aldicarb sulfoxide is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 致癌物分类

对人类不具有致癌性（未被国际癌症研究机构IARC列名）。

No indication of carcinogenicity to humans (not listed by IARC).

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 健康影响

急性暴露于胆碱酯酶抑制剂可能会导致胆碱能危象，表现为严重的恶心/呕吐、流涎、出汗、心动过缓、低血压、崩溃和抽搐。肌肉无力可能性增加，如果呼吸肌肉受累，可能会导致死亡。在运动神经积累的乙酰胆碱会导致神经肌肉接头处烟碱表达的过度刺激。当这种情况发生时，可以看到肌肉无力、疲劳、肌肉痉挛、肌肉颤动和麻痹的症状。当自主神经节积累乙酰胆碱时，这会导致交感系统中烟碱表达的过度刺激。与此相关的症状是高血压和低血糖。由于乙酰胆碱积累，中枢神经系统中烟碱乙酰胆碱受体的过度刺激会导致焦虑、头痛、抽搐、共济失调、呼吸和循环抑制、震颤、全身无力，甚至可能昏迷。当由于副交感神经乙酰胆碱受体处乙酰胆碱过多而出现毒蕈碱过度刺激时，可能会出现视力障碍、胸部紧绷、由于支气管收缩引起的喘息、支气管分泌物增加、唾液分泌增加、流泪、出汗、肠蠕动和排尿的症状。长期高（>10年）暴露会导致神经心理学后果，包括感知和视觉运动处理的干扰（A15321）。

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (A15321).

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 暴露途径

吸入（L793）；口服（L793）；皮肤给药（L793）

Inhalation (L793) ; oral (L793); dermal (L793)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 症状

与有机磷化合物一样，症状和体征基于过度的胆碱能刺激。与有机磷中毒不同，氨基甲酸酯中毒的持续时间往往较短，因为神经组织乙酰胆碱酯酶的抑制作用是可逆的，而且氨基甲酸酯的代谢速度更快。肌肉无力、眩晕、出汗和轻微的身体不适是常见的早期症状。头痛、流涎、恶心、呕吐、腹痛和腹泻在较高暴露水平时常常很明显。瞳孔收缩伴有视力模糊、不协调、肌肉抽搐和言语不清的情况也有报道。(L795)

As with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (L795)

来源:Toxin and Toxin Target Database (T3DB)

安全信息

• 危险等级：
  6.1(a)
• 危险品标志：
  T+
• 安全说明：
  S22
• 危险类别码：
  R28
• WGK Germany：
  3
• 危险品运输编号：
  UN 2757
• RTECS号：
  UE2075000
• 海关编码：
  2930909090
• 包装等级：
  I
• 危险类别：
  6.1(a)

制备方法与用途

用途

涕灭威亚砜是一种含有氨基甲酸酯的杀虫剂。这类农药具有选择性强、高效、广谱、对人畜低毒、易分解和残留少等特点，因此在农业、林业和畜牧业等领域得到了广泛应用。

反应信息

• 作为反应物：
  描述：

  Aldicarb sulfoxide 生成 2-methyl-2-methylsulfinyl-propanenitrile
  参考文献：
  名称：

  MOODY, R. P.;TRANKLIN, C.;RIDEL, D.;MUIR, N. I.;GREENHALGH, R.;HLADKA, A., J. AGR. AND FOOD CHEM., 1985, 33, N 3, 455-460

  摘要：

  DOI：
• 作为产物：
  描述：

  aldicarb 生成 Aldicarb sulfoxide
  参考文献：
  名称：

  MOODY, R. P.;TRANKLIN, C.;RIDEL, D.;MUIR, N. I.;GREENHALGH, R.;HLADKA, A., J. AGR. AND FOOD CHEM., 1985, 33, N 3, 455-460

  摘要：

  DOI：

文献信息

• Method and reagents for binding chemical analytes to a substrate surface, and related analytical devices and diagnostic techniques
  申请人：Hewlett-Packard Company

  公开号：EP0657737A2

  公开（公告）日：1995-06-14

  A method for detecting an analyte of interest in a sample includes the steps of binding the analyte to the surface of a substrate through a biotin-biotin binding protein interaction, contacting the surface-bound analyte with a quantitatively detectable analyte-binding moiety that binds thereto, measuring the quantity of detectable moiety bound to the substrate surface (11) and deriving therefrom the quantity of analyte in solution. A preferred use for the present method is in conjunction with a piezoelectric surface transverse wave device.

  一种检测样品中感兴趣的分析物的方法包括以下步骤：通过生物素-生物素结合蛋白的相互作用将分析物与基质表面结合；将表面结合的分析物与定量检测的分析物结合分子接触；测量与基质表面结合的可检测分子的数量（11），并由此得出溶液中分析物的数量。本方法最好与压电表面横波装置结合使用。
• A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1258729A2

  公开（公告）日：2002-11-20

  The present invention provides a method of selecting an antibody against a target substance to be measured which comprises selecting the antibody against the target substance by antigen-antibody reaction in the presence of a substance interfering with the antigen-antibody reaction. That is, an antigen and a labeled antigen are reacted with the antibody in the presence of an interfering substance such as an environment pollutant, and on the basis of the degree of reaction thereof, the antibody against the target substance highly resistant to the interfering substance is selected. Thereby, even if a test sample is contaminated with a substance interfering with antigen-antibody reaction, the antibody highly resistant to a substance interfering with antigen-antibody reaction is not influenced by the interfering substance and gives a correct value in the quantification.

  本发明提供了一种针对待测目标物质的抗体选择方法，该方法包括在干扰抗原-抗体反应的物质存在下，通过抗原-抗体反应选择针对目标物质的抗体。 也就是说，在干扰物质（如环境污染物）存在的情况下，抗原和标记抗原与抗体反应，根据反应程度选择对干扰物质具有高度抵抗力的目标物质抗体。这样，即使测试样品被干扰抗原-抗体反应的物质污染，对干扰抗原-抗体反应的物质具有高度抗性的抗体也不会受到干扰物质的影响，并能给出正确的定量值。
• Label-free method for the detection of analytes
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP2752664A1

  公开（公告）日：2014-07-09

  The present invention relates to method for the detection and/or characterization of an analyte based on determining and preferably optical determining the alteration of mechanical deformation of hydrogel particles and kits suitable for this method.

  本发明涉及基于测定（最好是光学测定）水凝胶颗粒机械变形的变化来检测和/或表征分析物的方法，以及适用于该方法的试剂盒。
• Techniques for display and processing of mass spectral data
  申请人：Waters Technologies Corporation

  公开号：US10768151B2

  公开（公告）日：2020-09-08

  Processing mass spectral data may include performing one or more experiments using one or more samples, each experiment including mass analysis using a mass spectrometer; acquiring one or more raw mass spectral data sets as a result of performing the one or more experiments; receiving selection criteria; filtering the one or more raw mass spectral data sets in accordance with the selection criteria; and generating a chromatogram as a result of said filtering, wherein the chromatogram displays signal intensity as a function of scan time for a plurality of scan times and includes a non-zero signal intensity at each scan time only if, at the scan time, the selection criteria is met and otherwise the chromatogram includes a zero signal intensity at the scan time. The mass spectrometer may alternate between low and elevated energy modes and acquire two of the raw mass spectral data sets concurrently.

  处理质谱数据可包括使用一个或多个样品执行一个或多个实验，每个实验包括使用质谱仪进行质量分析；作为执行一个或多个实验的结果获取一个或多个原始质谱数据集；接收选择标准；根据选择标准过滤一个或多个原始质谱数据集；其中，色谱图显示多个扫描时间的信号强度与扫描时间的函数关系，并且只有在扫描时间满足选择标准时，色谱图才包括每个扫描时间的非零信号强度，否则色谱图包括扫描时间的零信号强度。质谱仪可交替使用低能模式和高能模式，并同时获取两个原始质谱数据集。
• Vaporizable tobacco wax compositions and container thereof
  申请人：Bond Street Manufacturing LLC

  公开号：US10918127B2

  公开（公告）日：2021-02-16

  The invention relates to tobacco wax compositions suitable for use in a vaporizer. The tobacco wax may comprise additional excipients including vapor agents, penetration agents, buffer agents, and rheological agents. The composition contains nicotine. The tobacco wax composition leaves a minimum of residue in the vaporizer when used. In another aspect, the invention relates to a portion-sized container (“pod”) of a tobacco wax composition for administration to a mammal or person. The pod is intended for use in a personal (or other) vaporizer.

  本发明涉及适用于蒸发器的烟草蜡组合物。烟蜡可包含其他辅料，包括蒸发剂、渗透剂、缓冲剂和流变剂。该组合物含有尼古丁。使用时，烟草蜡组合物在蒸发器中的残留物最少。另一方面，本发明涉及一种用于哺乳动物或人的烟草蜡组合物的分装容器（"荚"）。豆荚用于个人（或其他）喷雾器。